Bhalgat was chief operating officer of Syngene International, the biggest contract research, development, and manufacturing organization in India, before joining Veeda.
Mahesh Bhalgat was named Group CEO of Veeda Clinical Research, a full-service clinical research company (CRO) with its headquarters in Ahmedabad, on Thursday.
Bhalgat was chief operating officer of Syngene International, the biggest contract research, development, and manufacturing organization in India, before joining Veeda.
Mahesh has extensive experience holding key executive positions at Biological E, Sanofi, and Amgen.
“The joining of Mahesh (Bhalgat), a highly accomplished Pharma-Biotech industry veteran, reflects the strong commitment across the group companies to becoming a leading contract research group by expanding its footprint beyond India and offering a comprehensive set of research services for diverse clients serving both early and late-stage global clinical development programs,” said Vivek Chhachhi, board member and director at Veeda Clinical Research.
“He will focus on business growth, including mergers and acquisitions, leveraging technology and client centricity to bring the best of Veeda’s service portfolios to global clients,” Chhachhi added.
Veeda provides both early and late-phase clinical trials in addition to a variety of bioequivalency findings.
Also read: Women in the technology industry is constantly increasing, says Rajita Bhatnagar
Do Follow: CIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter
About us:
CIO News, a proprietary of Mercadeo, produces award-winning content and resources for IT leaders across any industry through print articles and recorded video interviews on topics in the technology sector such as Digital Transformation, Artificial Intelligence (AI), Machine Learning (ML), Cloud, Robotics, Cyber-security, Data, Analytics, SOC, SASE, among other technology topics.
